Hepatocellular Carcinoma
📧 Sign up to get email alerts when something new happens for Hepatocellular Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-02-08Clinical Trial Update: The Phase III Study of Icaritin Versus Sorafenib in PD-L1 Positive Advanced Hepatocellular Carcinoma Subjects [Phase 3]
Phase III study comparing Icaritin to Sorafenib in PD-L1 positive advanced hepatocellular carcinoma was terminated.
-
CLINICAL_TRIALS trial_result · 2023-02-06Clinical Trial Update: Study of TACE Combined With Lenvatinib to Prevent Postoperative Recurrence in Patients With MVI Positive HCC [Phase 1, Phase 2]
A combined TACE and Lenvatinib trial in hepatocellular carcinoma with microvascular invasion aims to prevent postoperative recurrence; curre…
-
CLINICAL_TRIALS trial_result · 2023-02-06Clinical Trial Update: A Phase Ib/II Study of Fisogatinib(BLU-554) in Subjects With Hepatocellular Carcinoma [Phase 1, Phase 2]
Phase Ib/II study of Fisogatinib (BLU-554) in hepatocellular carcinoma has completed; results posted in 2023.
-
CLINICAL_TRIALS trial_result · 2023-02-01Clinical Trial Update: Neoadjuvant Anti-PD1 in HCC [Phase 2]
Phase 2 neoadjuvant anti-PD1 trial in hepatocellular carcinoma completed.
-
CLINICAL_TRIALS trial_result · 2023-02-01Clinical Trial Update: Atezolizumab and Bevacizumab Pre-Liver Transplantation for Patients With Hepatocellular Carcinoma Beyond Milan Criteria [Phase 4]
Phase 4 trial investigating atezolizumab and bevacizumab before liver transplantation in hepatocellular carcinoma patients beyond Milan crit…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2023-01-30Clinical Trial Update: Simo Decoction and Gum Chewing for Bowel Activity [Phase 3]
Phase 3 clinical trial update investigating Simo Decoction and gum chewing for bowel activity in hepatocellular carcinoma patients has compl…
-
CLINICAL_TRIALS trial_result · 2023-01-27Clinical Trial Update: Adjuvant Radiotherapy Comparing TACE for Curative HCC [Phase 3]
A Phase 3 clinical trial comparing adjuvant radiotherapy versus transarterial chemoembolization (TACE) for curative treatment in hepatocellu…
-
CLINICAL_TRIALS trial_result · 2023-01-26Clinical Trial Update: Durvalumab Plus Lenvatinib as First-line Treatment for Unresectable Hepatocellular Carcinoma [Phase 2]
A Phase 2 clinical trial assesses durvalumab plus lenvatinib as first-line therapy for unresectable hepatocellular carcinoma.
-
CLINICAL_TRIALS trial_result · 2023-01-17Clinical Trial Update: Anlotinib Combined With TACE in Hepatocellular Carcinoma Patients at High Risk of Post Surgery Recurrence [Phase 2]
Phase 2 trial evaluating anlotinib in combination with TACE for hepatocellular carcinoma patients at high risk of post-surgical recurrence.
-
CLINICAL_TRIALS trial_result · 2023-01-10Clinical Trial Update: [68Ga]DOTATATE-PET/MRI in Hepatocellular Carcinoma [Phase 1, Phase 2]
Phase 1/2 trial evaluating [68Ga]DOTATATE-PET/MRI in hepatocellular carcinoma has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2023-01-06Clinical Trial Update: Intraprocedural Assessment of Ablation Margins Using Computed Tomography Co-registration in Primary Liver Tumor Treatment With Percutaneous Ablation [Phase 2]
Phase 2 trial update on intraprocedural assessment of ablation margins using CT co-registration in percutaneous ablation for hepatocellular …
-
CLINICAL_TRIALS trial_result · 2022-12-30Clinical Trial Update: Trial to Evaluate the Safety of Talimogene Laherparepvec Injected Into Tumors Alone and in Combination With Systemic Pembrolizumab MK-3475-611/Keynote-611 [Phase 1, Phase 2]
A phase 1/2 clinical trial evaluated the safety of Talimogene laherparepvec injected into tumors alone and in combination with pembrolizumab…
-
CLINICAL_TRIALS trial_result · 2022-12-29Clinical Trial Update: Lipiodol-TACE With Idarubicin for Hepatocellular Carcinoma [Phase 2, Phase 3]
Clinical trial update on Lipiodol-TACE with idarubicin for hepatocellular carcinoma across Phase 2 and Phase 3.
-
CLINICAL_TRIALS trial_result · 2022-12-29Clinical Trial Update: TACE Combined With Penpulimab and Anlotinib for Advanced HCC [Phase 2, Phase 3]
Phase 2/3 trial evaluating TACE with penpulimab and anlotinib for advanced hepatocellular carcinoma is ongoing with unknown status.
-
CLINICAL_TRIALS trial_result · 2022-12-20Clinical Trial Update: Determination of HCC With Octanoate Breath Test vs. MRI Diagnosis [Phase 2]
Phase 2 trial comparing octanoate breath test to MRI for diagnosis of hepatocellular carcinoma (HCC) completed.
-
CLINICAL_TRIALS trial_result · 2022-12-16Clinical Trial Update: Prophylactic Antibiotic Use in Transarterial Chemoembolization for Hepatocellular Carcinoma [Phase 3]
Phase 3 clinical trial update evaluating prophylactic antibiotic use during transarterial chemoembolization for hepatocellular carcinoma. Cu…
-
CLINICAL_TRIALS trial_result · 2022-12-15Clinical Trial Update: AK104 Combining With TACE for Resectable Hepatocellular Carcinoma (MORNING) [Phase 2]
Phase 2 clinical trial evaluating AK104 in combination with TACE for resectable hepatocellular carcinoma.
-
CLINICAL_TRIALS trial_result · 2022-12-14Clinical Trial Update: Abemaciclib and Nivolumab for Subjects With Hepatocellular Carcinoma [Phase 2]
Phase 2 trial of abemaciclib plus nivolumab in hepatocellular carcinoma was terminated; results posted in 2022.
-
CLINICAL_TRIALS trial_result · 2022-12-13Clinical Trial Update: Safety and Bioactivity of Ipilimumab and Nivolumab Combination Prior to Liver Resection in Hepatocellular Carcinoma [Phase 1, Phase 2]
Phase 1/2 trial updating safety and bioactivity of ipilimumab plus nivolumab before liver resection in hepatocellular carcinoma.
-
CLINICAL_TRIALS trial_result · 2022-12-09Clinical Trial Update: HAIC With One-day FOLFOX vs. HAIC With Two-day FOLFOX for Unresectable HCC: a Non-inferiority Study [Phase 3]
Phase 3 trial comparing HAIC with one-day FOLFOX versus two-day FOLFOX for unresectable hepatocellular carcinoma; currently recruiting non-i…
-
CLINICAL_TRIALS trial_result · 2022-12-06Clinical Trial Update: Combination of Regorafenib and Nivolumab in Unresectable Hepatocellular Carcinoma [Phase 2]
Phase 2 trial evaluating regorafenib combined with nivolumab in unresectable hepatocellular carcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2022-12-06Clinical Trial Update: Low-dose Y90 Treatment Planning for HCC [NA]
A completed clinical trial investigating low-dose Yttrium-90 treatment planning for hepatocellular carcinoma (HCC) with results posted in 20…
-
CLINICAL_TRIALS trial_result · 2022-11-29Clinical Trial Update: Toripalimab Combined With Donafenib in the Treatment of Advanced Hepatocellular Carcinoma [Phase 1, Phase 2]
Clinical trial updates on toripalimab combined with donafenib for advanced hepatocellular carcinoma across Phase 1 and Phase 2.
-
CLINICAL_TRIALS trial_result · 2022-11-28Clinical Trial Update: Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors [Phase 2]
A Phase 2 clinical trial evaluating cabozantinib-s-maleate in pediatric patients with recurrent, refractory, or newly diagnosed sarcomas, Wi…
-
CLINICAL_TRIALS trial_result · 2022-11-17Clinical Trial Update: Safety and Efficacy of Bifidobacterium Therapy in Patients With Advanced Liver Cancer Receiving Immunotherapy [Phase 1, Phase 2]
A clinical trial update assessing safety and efficacy of Bifidobacterium therapy in patients with advanced hepatocellular carcinoma undergoi…